Critically ill patients who received 300,000 IU of Vitamin D were 40% less likely to die within a month - meta-analysis
Vitamin D supplementation and mortality among critically ill adults: a systematic review and meta-analysis
Front Nutr. 2026 Jun 22:13:1796272. doi: 10.3389/fnut.2026.1796272
Chienhsiu Huang - Taiwan
Background: Randomized controlled trials have failed to demonstrate the effects of vitamin D supplementation on reducing the mortality rate in critically ill adults. A post hoc study revealed that vitamin D administration was linked to a lower 28-day mortality rate. The purpose of this meta-analysis was to investigate how vitamin D supplementation affects mortality in critically ill adults. The effects of vitamin D supplementation, such as baseline 25-hydroxyvitamin D level, vitamin D supplementation dosage, and vitamin D delivery route, were given special attention in relevant subgroups.
Methods: The inclusion criteria for eligible studies were as follows: (1) randomized controlled trials; (2) critically ill adults; (3) the intervention group was given vitamin D or a vitamin D metabolite without any restrictions on type, dosage, duration, or route of administration; and (4). the outcome of mortality in critically ill adults.
Results: Subgroup analysis revealed the following findings: (1) there was a trend toward reduced mortality in critically ill adults whose baseline 25-hydroxyvitamin D level was less than 20 ng/mL (RR = 0.87, p = 0.05, 95% CI = 0.76-1.00, I 2 = 31%). Meta-analysis revealed a relative risk of mortality of 0.87, indicating that patients with baseline 25-hydroxyvitamin D level less than 20 ng/mL receiving vitamin D supplementation had a 13% lower risk of death than controls; (2) mortality was significantly reduced in patients who received ≤300,000 IU of vitamin D compared with those who received the placebo, (RR = 0.56, p < 0.0001, 95% CI = 0.42-0.74, I 2 = 0%); (3) administration by intramuscular injection or intravenous injection significantly reduced the risk of mortality (RR = 0.59, p = 0.0006, 95% CI = 0.44-0.80, I 2 = 0%).
Conclusion: This meta-analysis revealed that vitamin D supplementation significantly reduced mortality in critically ill adult patients, but not all patients benefited. The benefit was observed in three subgroups of patients as below: (1) critically ill adults with baseline 25-hydroxyvitamin D levels below 20 ng/mL; (2) critically ill adults receiving ≤300,000 IU of vitamin D supplementation; (3) critically ill adults receiving the supplement via intramuscular or intravenous injection.
Systematic review registration: CRD420251152462.
Related in VitaminDWiki
- 14 types of surgeries improved by Vitamin D - RCTs Dec 2025
- ICU trials typically use 300,000 IU of Vitamin D - meta-analysis
- 5,000 ICU patients have benefited from Vitamin D
- Vitamin D loading doses typically helped critically ill, but never harmed (21 RCTs)
- ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies
- Critically ill trauma patients - virtually none had even 30 ng of Vitamin D
- Large dose Vitamin D before surgery was found to help by 35 studies